These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 35438754)

  • 21. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial.
    Puskarich MA; Ingraham NE; Merck LH; Driver BE; Wacker DA; Black LP; Jones AE; Fletcher CV; South AM; Murray TA; Lewandowski C; Farhat J; Benoit JL; Biros MH; Cherabuddi K; Chipman JG; Schacker TW; Guirgis FW; Voelker HT; Koopmeiners JS; Tignanelli CJ;
    JAMA Netw Open; 2022 Mar; 5(3):e222735. PubMed ID: 35294537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.
    Diago-Sempere E; Bueno JL; Sancho-López A; Rubio EM; Torres F; de Molina RM; Fernández-Cruz A; de Diego IS; Velasco-Iglesias A; Payares-Herrera C; Flecha IC; Avendaño-Solà C; Palomino RD; Ramos-Martínez A; Ruiz-Antorán B
    Trials; 2021 Jan; 22(1):70. PubMed ID: 33472681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Estcourt LJ; Turgeon AF; McQuilten ZK; McVerry BJ; Al-Beidh F; Annane D; Arabi YM; Arnold DM; Beane A; Bégin P; van Bentum-Puijk W; Berry LR; Bhimani Z; Birchall JE; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Callum JL; Chassé M; Cheng AC; Cove ME; Daly J; Derde L; Detry MA; De Jong M; Evans A; Fergusson DA; Fish M; Fitzgerald M; Foley C; Goossens H; Gordon AC; Gosbell IB; Green C; Haniffa R; Harvala H; Higgins AM; Hills TE; Hoad VC; Horvat C; Huang DT; Hudson CL; Ichihara N; Laing E; Lamikanra AA; Lamontagne F; Lawler PR; Linstrum K; Litton E; Lorenzi E; MacLennan S; Marshall J; McAuley DF; McDyer JF; McGlothlin A; McGuinness S; Miflin G; Montgomery S; Mouncey PR; Murthy S; Nichol A; Parke R; Parker JC; Priddee N; Purcell DFJ; Reyes LF; Richardson P; Robitaille N; Rowan KM; Rynne J; Saito H; Santos M; Saunders CT; Serpa Neto A; Seymour CW; Silversides JA; Tinmouth AA; Triulzi DJ; Turner AM; van de Veerdonk F; Walsh TS; Wood EM; Berry S; Lewis RJ; Menon DK; McArthur C; Zarychanski R; Angus DC; Webb SA; Roberts DJ; Shankar-Hari M
    JAMA; 2021 Nov; 326(17):1690-1702. PubMed ID: 34606578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
    Caricchio R; Abbate A; Gordeev I; Meng J; Hsue PY; Neogi T; Arduino R; Fomina D; Bogdanov R; Stepanenko T; Ruiz-Seco P; Gónzalez-García A; Chen Y; Li Y; Whelan S; Noviello S;
    JAMA; 2021 Jul; 326(3):230-239. PubMed ID: 34283183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
    Cairns DM; Dulko D; Griffiths JK; Golan Y; Cohen T; Trinquart L; Price LL; Beaulac KR; Selker HP
    JAMA Netw Open; 2022 Feb; 5(2):e2144942. PubMed ID: 35138402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
    Diaz R; Orlandini A; Castellana N; Caccavo A; Corral P; Corral G; Chacón C; Lamelas P; Botto F; Díaz ML; Domínguez JM; Pascual A; Rovito C; Galatte A; Scarafia F; Sued O; Gutierrez O; Jolly SS; Miró JM; Eikelboom J; Loeb M; Maggioni AP; Bhatt DL; Yusuf S;
    JAMA Netw Open; 2021 Dec; 4(12):e2141328. PubMed ID: 34964849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Self WH; Semler MW; Leither LM; Casey JD; Angus DC; Brower RG; Chang SY; Collins SP; Eppensteiner JC; Filbin MR; Files DC; Gibbs KW; Ginde AA; Gong MN; Harrell FE; Hayden DL; Hough CL; Johnson NJ; Khan A; Lindsell CJ; Matthay MA; Moss M; Park PK; Rice TW; Robinson BRH; Schoenfeld DA; Shapiro NI; Steingrub JS; Ulysse CA; Weissman A; Yealy DM; Thompson BT; Brown SM; ; Steingrub J; Smithline H; Tiru B; Tidswell M; Kozikowski L; Thornton-Thompson S; De Souza L; Hou P; Baron R; Massaro A; Aisiku I; Fredenburgh L; Seethala R; Johnsky L; Riker R; Seder D; May T; Baumann M; Eldridge A; Lord C; Shapiro N; Talmor D; O’Mara T; Kirk C; Harrison K; Kurt L; Schermerhorn M; Banner-Goodspeed V; Boyle K; Dubosh N; Filbin M; Hibbert K; Parry B; Lavin-Parsons K; Pulido N; Lilley B; Lodenstein C; Margolin J; Brait K; Jones A; Galbraith J; Peacock R; Nandi U; Wachs T; Matthay M; Liu K; Kangelaris K; Wang R; Calfee C; Yee K; Hendey G; Chang S; Lim G; Qadir N; Tam A; Beutler R; Levitt J; Wilson J; Rogers A; Vojnik R; Roque J; Albertson T; Chenoweth J; Adams J; Pearson S; Juarez M; Almasri E; Fayed M; Hughes A; Hillard S; Huebinger R; Wang H; Vidales E; Patel B; Ginde A; Moss M; Baduashvili A; McKeehan J; Finck L; Higgins C; Howell M; Douglas I; Haukoos J; Hiller T; Lyle C; Cupelo A; Caruso E; Camacho C; Gravitz S; Finigan J; Griesmer C; Park P; Hyzy R; Nelson K; McDonough K; Olbrich N; Williams M; Kapoor R; Nash J; Willig M; Ford H; Gardner-Gray J; Ramesh M; Moses M; Ng Gong M; Aboodi M; Asghar A; Amosu O; Torres M; Kaur S; Chen JT; Hope A; Lopez B; Rosales K; Young You J; Mosier J; Hypes C; Natt B; Borg B; Salvagio Campbell E; Hite RD; Hudock K; Cresie A; Alhasan F; Gomez-Arroyo J; Duggal A; Mehkri O; Hastings A; Sahoo D; Abi Fadel F; Gole S; Shaner V; Wimer A; Meli Y; King A; Terndrup T; Exline M; Pannu S; Robart E; Karow S; Hough C; Robinson B; Johnson N; Henning D; Campo M; Gundel S; Seghal S; Katsandres S; Dean S; Khan A; Krol O; Jouzestani M; Huynh P; Weissman A; Yealy D; Scholl D; Adams P; McVerry B; Huang D; Angus D; Schooler J; Moore S; Files C; Miller C; Gibbs K; LaRose M; Flores L; Koehler L; Morse C; Sanders J; Langford C; Nanney K; MdalaGausi M; Yeboah P; Morris P; Sturgill J; Seif S; Cassity E; Dhar S; de Wit M; Mason J; Goodwin A; Hall G; Grady A; Chamberlain A; Brown S; Bledsoe J; Leither L; Peltan I; Starr N; Fergus M; Aston V; Montgomery Q; Smith R; Merrill M; Brown K; Armbruster B; Harris E; Middleton E; Paine R; Johnson S; Barrios M; Eppensteiner J; Limkakeng A; McGowan L; Porter T; Bouffler A; Leahy JC; deBoisblanc B; Lammi M; Happel K; Lauto P; Self W; Casey J; Semler M; Collins S; Harrell F; Lindsell C; Rice T; Stubblefield W; Gray C; Johnson J; Roth M; Hays M; Torr D; Zakaria A; Schoenfeld D; Thompson T; Hayden D; Ringwood N; Oldmixon C; Ulysse C; Morse R; Muzikansky A; Fitzgerald L; Whitaker S; Lagakos A; Brower R; Reineck L; Aggarwal N; Bienstock K; Freemer M; Maclawiw M; Weinmann G; Morrison L; Gillespie M; Kryscio R; Brodie D; Zareba W; Rompalo A; Boeckh M; Parsons P; Christie J; Hall J; Horton N; Zoloth L; Dickert N; Diercks D
    JAMA; 2020 Dec; 324(21):2165-2176. PubMed ID: 33165621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
    Bar KJ; Shaw PA; Choi GH; Aqui N; Fesnak A; Yang JB; Soto-Calderon H; Grajales L; Starr J; Andronov M; Mastellone M; Amonu C; Feret G; DeMarshall M; Buchanan M; Caturla M; Gordon J; Wanicur A; Monroy MA; Mampe F; Lindemuth E; Gouma S; Mullin AM; Barilla H; Pronina A; Irwin L; Thomas R; Eichinger RA; Demuth F; Luning Prak ET; Pascual JL; Short WR; Elovitz MA; Baron J; Meyer NJ; Degnan KO; Frank I; Hensley SE; Siegel DL; Tebas P
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34788233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
    Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
    Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
    Deftereos SG; Giannopoulos G; Vrachatis DA; Siasos GD; Giotaki SG; Gargalianos P; Metallidis S; Sianos G; Baltagiannis S; Panagopoulos P; Dolianitis K; Randou E; Syrigos K; Kotanidou A; Koulouris NG; Milionis H; Sipsas N; Gogos C; Tsoukalas G; Olympios CD; Tsagalou E; Migdalis I; Gerakari S; Angelidis C; Alexopoulos D; Davlouros P; Hahalis G; Kanonidis I; Katritsis D; Kolettis T; Manolis AS; Michalis L; Naka KK; Pyrgakis VN; Toutouzas KP; Triposkiadis F; Tsioufis K; Vavouranakis E; Martinèz-Dolz L; Reimers B; Stefanini GG; Cleman M; Goudevenos J; Tsiodras S; Tousoulis D; Iliodromitis E; Mehran R; Dangas G; Stefanadis C;
    JAMA Netw Open; 2020 Jun; 3(6):e2013136. PubMed ID: 32579195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    Balcells ME; Rojas L; Le Corre N; Martínez-Valdebenito C; Ceballos ME; Ferrés M; Chang M; Vizcaya C; Mondaca S; Huete Á; Castro R; Sarmiento M; Villarroel L; Pizarro A; Ross P; Santander J; Lara B; Ferrada M; Vargas-Salas S; Beltrán-Pavez C; Soto-Rifo R; Valiente-Echeverría F; Caglevic C; Mahave M; Selman C; Gazitúa R; Briones JL; Villarroel-Espindola F; Balmaceda C; Espinoza MA; Pereira J; Nervi B
    PLoS Med; 2021 Mar; 18(3):e1003415. PubMed ID: 33657114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
    Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
    JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.